Stay updated on Capivasertib+Abiraterone in PTEN-deficient Prostate Clinical Trial
Sign up to get notified when there's something new on the Capivasertib+Abiraterone in PTEN-deficient Prostate Clinical Trial page.

Latest updates to the Capivasertib+Abiraterone in PTEN-deficient Prostate Clinical Trial page
- Check2 days agoChange DetectedA new revision entry labeled v3.5.4 was added to the history, superseding v3.5.3. This represents a minor metadata update to the page's version history rather than a substantive change to the page content.SummaryDifference0.1%

- Check9 days agoChange DetectedA new version entry (Version 51) has been added to the record history, including a Study Status update dated 2026-05-04 and a follow-up note dated 2026-05-05. This indicates ongoing documentation of changes to the study record on ClinicalTrials.gov.SummaryDifference0.2%

- Check16 days agoChange DetectedThe record history adds a new revision entry v3.5.3 and removes v3.5.2, updating the historical log shown on the page. This is an administrative update to the revision history rather than a change to study data or page functionality.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe bottom revision tag updates from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check45 days agoChange DetectedAdded Contacts/Locations and Study Status sections to the record history, reflecting updated site details and current trial status. The latest version shows these updates in the study record and status history.SummaryDifference0.3%

- Check59 days agoChange Detected- Added Revision: v3.5.0; Removed Revision: v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Capivasertib+Abiraterone in PTEN-deficient Prostate Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Capivasertib+Abiraterone in PTEN-deficient Prostate Clinical Trial page.